http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102171012-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2019-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102171012-B1 |
| titleOfInvention | Method for diagnosing liver disease or liver cancer using salsolinol and biomarker composition |
| abstract | The present invention relates to a method for gender-specific diagnosis of liver disease or liver cancer by measuring the concentration of salsolinol, which is a metabolite in a biological sample, and comparing it with the concentration of salsolinol in a normal subject. In addition to being able to diagnose liver cancer more accurately, it can be usefully used in gender-specific biomarker compositions and kits. |
| priorityDate | 2018-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 606.